Insider Transactions

What ImmunoGen, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Arbuckle Stuart A	Director	Feb 12	Disposition to Issuer · D	−5,381	—	—	0
Vasconcelles Michael	EVP R&D & MEDICAL AFFAIRS	Feb 12	Disposition to Issuer · D	−1,327	—	—	0
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Feb 12	Disposition to Issuer · D	−584,397	—	—	0
Mitchell Dean J	Director	Feb 12	Disposition to Issuer · D	−103,000	—	—	0
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Feb 12	Disposition to Issuer · D	−21,039	—	—	0
Wallace Richard John	Director	Feb 12	Disposition to Issuer · D	−10,000	—	—	0
Char Daniel	SVP & CHIEF LEGAL OFFICER	Feb 12	Disposition to Issuer · D	−1,000	—	—	0
Thackray Helen M.	Director	Feb 12	Disposition to Issuer · D	−3,074	—	—	0
Goldberg Mark Alan	Director	Feb 12	Disposition to Issuer · D	−60,720	—	—	0
Lentini Renee	VP & PRIN ACCTG OFFICER	Feb 12	Disposition to Issuer · D	−14,723	—	—	0
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Feb 12	Disposition to Issuer · D	−73,274	—	—	0
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Feb 05	Open-market sale · S	−20,107	$29.28	−$589K	584,397
Lentini Renee	VP & PRIN ACCTG OFFICER	Feb 05	Open-market sale · S	−2,631	$29.30	−$77.1K	14,723
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Feb 05	Open-market sale · S	−4,583	$29.30	−$134K	73,274
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Feb 05	Open-market sale · S	−12,027	$29.30	−$352K	21,039
Enyedy Mark J	CHIEF EXECUTIVE OFFICER	Feb 02	Exercise / conversion · M	+51,234	—	—	604,504
Lentini Renee	VP & PRIN ACCTG OFFICER	Feb 02	Exercise / conversion · M	+8,435	—	—	17,354
Coen Stacy Ann	SVP & CHIEF BUSINESS OFFICER	Feb 02	Exercise / conversion · M	+14,350	—	—	77,857
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Feb 02	Exercise / conversion · M	+29,640	—	—	33,066
Wingrove Theresa	SVP OF REGULATORY AFFAIRS	Jan 16	Open-market sale · S	−187,667	$29.64	−$5.56M	3,426

Page 1 of 32 · showing the 20 most recent Sign up free to view all 633 transactions and filter by insider →

Comments